You searched for "intervention"
IL-25 and nasal polyps, another target
Immune response in chronic rhinosinusitis with nasal polyps (CRSwNP) is mainly via type 2 T-helper (Th2) cells while Th1 cells characterise chronic rhinosinusitis without nasal polyps (CRSsNP) immune response. CRSwNP is heterogeneous on a cytological level causing a varied response...
Eosinophilic or not eosinophilic: dupilumab seems to work
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a type 2 inflammation with interleukin (IL)-4, IL-13, and IL-5. Tissue eosinophilia in nasal polyps dramatically increased over a 10-20-year period. Classification of the severity of eosinophil status is expected to lead to...74th National Congress of SEORL-CCC/XIX congreso Hispano-Luso
Alfonso Santamaría Gadea, Departamento de Otorrinolaringología, Hospital Universitario Ramón y Cajal, Madrid, Spain. The 74th edition of the Spanish Society of Otorhinolaryngology and Head and Neck Surgery (SEORL-CCC) National Congress took place at the Meliá Castilla Hotel in Madrid under...National Conference of the Romanian Society of ENT and Cervico-Facial Surgery, with international participation
Prof. Hesham Negm, Cairo University, Egypt, and Dr. Gloria Monteanu, Medical Faculty UMF and Carol Davila University of Medicine and Pharmacy, Bucharest, Romania In the heart of Romania, Poiana Brasov is not only an extraordinary place for holding a scientific...Robotic‑assisted cochlear implant insertion approved by FDA
The Minnesota-based medical technology company iotaMotion has announced a "meaningful milestone in peadiatric hearing care", having received clearance from the US Food and Drug Administration (FDA) for the iotaSoft® robotic‑assisted cochlear implant insertion system for children aged four and older.
Maturation of BC attenuation
The aim of this study was to clarify the reason for differences between bone-conduction hearing in adults and infants. The authors investigated how the sound pressure level in the ear canal changes depending on the bone-conduction transducer placement. By using...Access to and uptake of cochlear implants in the UK
Assessing demands on cochlear implant (CI) services is very important for both commissioners and clinicians in anticipating clinical need and funding requirements. Commercial CI’s were introduced in the late 1980s. Initial funding was from charitable sources. The first major advance...Quo vadis FESS? Future directions in functional endoscopic sinus surgery
Endoscopic sinus surgery is now so ubiquitous that it is hard to imagine a time when it was not part of our clinical practice. Valentin Tomazic takes a look at its early development and looks ahead to endoscopic sinus surgery...Ear, nose and throat surgery in children – where will it be in 15 and 50 years?
Michael Kuo, David Albert and Mike Saunders have put their collective heads together to predict the future of ENT surgery in children; will there be a rise in workload due to increasing survival of children with complex medical problems? Or...Lancet Commission on Hearing Loss
The Lancet Commission on Hearing Loss was convened in 2019, and its main report will be published in 2023. We learn more about it here. The Lancet Commission on Hearing Loss was convened in 2019, and was charged by Richard...
